Drug tracked in tissue
When a new drug is developed, the manufacturer must be able to show that it reaches its intended goal in the body's tissue, and only that goal. Such studies could be made easier with a new method now established at Lund University in Sweden.
The method is a special type of mass spectrometry which can be used on drugs 'off the shelf', i.e. without any radioactive labelling which may change the behaviour of the drug. With this method, researchers György Marko-Varga and Thomas Fehniger have managed to create a molecular image of the drug in the tissue.
The tissue examined comes from biopsies from the lungs of patients with lung cancer and chronic obstructive lung disease (COPD), who have inhaled a drug to dilate the airways. The examination showed the precise spatial distribution of the drug within the tissue. The results are based on an analysis of 3 000 measurement points of 0.01 mm2 in each biopsy sample.
"When you want to register a new drug, you must be able to both explain its exact mechanisms of action and show that it is effective and safe. In order to avoid side-effects, the drug should reach only the cells for which it is intended. Our new technical platform makes it easier to show this", says György Marko-Varga.
He believes it will be possible to use the new technology to develop safer and more effective drug candidates. In the future it could also be used in clinical treatment, to help doctors select the right drug for a specific patient.
The researchers first conducted animal experiments, using drug doses 100 times higher than those now measured in patients. The group then optimised and refined the technology to achieve the sensitivity needed for measuring doses of drugs normally administered to patients.
Professors György Marko-Varga and Thomas Fehniger are both members of the Department of Measurement Technology and Industrial Electrical Engineering in Lund. Thomas Fehniger (who is the principal author of the article) is currently working at The Tallinn University of Technology, sponsored by the Estonian Science Foundation under the European Social Fund, while György Marko-Varga works part time for the University of Tokyo.
The two researchers have previously worked at the pharmaceuticals company AstraZeneca, which has also contributed to the study. The study was recently published in the journal Analytical Chemistry.
More information: A text about the research findings is available at http://pubs.acs.or … 41scene.html and the research article is available at http://pubs.acs.org/doi/abs/10.1021/ac2014349
Provided by Lund University
-
From lemons to lemonade: Reaction uses carbon dioxide to make carbon-based semiconductor,
32 comments
-
Thioridazine kills cancer stem cells in human while avoiding toxic side-effects of conventional cancer treatments,
3 comments
-
SpaceX private rocket blasts off for space station (Update),
42 comments
-
Climate scientists say they have solved riddle of rising sea,
31 comments
-
SpaceX capsule has 'new car' smell, astronauts say (Update),
3 comments
-
Gibbs Free Energy Change/Entropy
8 hours ago
-
What's the rule to covalent character
9 hours ago
-
Schwartz reagent-- NMR/MS/IR
May 26, 2012
-
High school chemistry EEI
May 25, 2012
-
oxidation of I- by KMnO4
May 25, 2012
-
Inversion temp
May 25, 2012
- More from Physics Forums - Chemistry
More news stories
Computer model used to pinpoint prime materials for efficient carbon capture
When power plants begin capturing their carbon emissions to reduce greenhouse gases – and to most in the electric power industry, it's a question of when, not if – it will be an expensive undertaking.
1 hour ago |
not rated yet |
0
|
Scientists develop ultra-sensitive test that detects diseases in their earliest stages
Scientists have developed an ultra-sensitive test that should enable them to detect signs of a disease in its earliest stages, in research published today in the journal Nature Materials.
Chemistry / Analytical Chemistry
1 hour ago |
not rated yet |
0
|
New CO2-removing catalyst can take the heat
(Phys.org) -- The current method of removing the greenhouse gas carbon dioxide (CO2) from the flues of coal-fired power plants uses so much energy that no one bothers to use it. So says Roger Aines, principal ...
May 24, 2012 |
5 / 5 (9) |
10
|
High-speed method to aid search for solar energy storage catalysts
Eons ago, nature solved the problem of converting solar energy to fuels by inventing the process of photosynthesis.
May 25, 2012 |
5 / 5 (3) |
4
|
Researchers demonstrate possible primitive mechanism of chemical info self-replication
(Phys.org) -- When scientists think about the replication of information in chemistry, they usually have in mind something akin to what happens in living organisms when DNA gets copied: a double-stranded molecule ...
May 25, 2012 |
5 / 5 (4) |
2
|
'Unzipped' carbon nanotubes could help energize fuel cells, batteries
Multi-walled carbon nanotubes riddled with defects and impurities on the outside could replace some of the expensive platinum catalysts used in fuel cells and metal-air batteries, according to scientists at ...
T cells 'hunt' parasites like animal predators seek prey, study shows
By pairing an intimate knowledge of immune-system function with a deep understanding of statistical physics, a cross-disciplinary team at the University of Pennsylvania has arrived at a surprising finding: T cells use a movement ...
Yale study concludes public apathy over climate change unrelated to science literacy
Are members of the public divided about climate change because they don't understand the science behind it? If Americans knew more basic science and were more proficient in technical reasoning, would public consensus match ...
Same gene that stunts infants' growth also makes them grow too big: research
UCLA geneticists have identified the mutation responsible for IMAGe* syndrome, a rare disorder that stunts infants' growth. The twist? The mutation occurs on the same gene that causes Beckwith-Wiedemann syndrome, which makes ...
Change in developmental timing was crucial in the evolutionary shift from dinosaurs to birds: study
At first glance, it's hard to see how a common house sparrow and a Tyrannosaurus Rex might have anything in common. After all, one is a bird that weighs less than an ounce, and the other is a dinosaur that ...
Manufacturing genes to attack flu virus
An international research team has manufactured a new protein that can combat deadly flu epidemics.
